期刊文献+

晚期糖基化终产物受体RAGE在宫颈鳞癌组织中的表达及临床意义 被引量:5

Expression of RAGE Protein in Human Cervical Squamous Cell Carcinoma
暂未订购
导出
摘要 目的:探讨宫颈鳞癌组织中晚期糖基化终产物受体(RAGE)表达情况及其与肿瘤分化程度、大小、分期、浸润和转移的关系。方法:应用免疫组织化学方法检测了30例宫颈原位癌、90例无转移的宫颈癌、30例有转移的宫颈癌和30例正常宫颈鳞状上皮中RAGE表达情况,并应用Western blot技术定量检测其表达情况。结果:RAGE在宫颈鳞癌组织中呈强阳性表达48.0%(72/150),正常宫颈鳞状上皮中弱表达13.3%,差异具有显著性(P<0.01),RAGE的高表达与宫颈鳞癌的发生、分期、侵袭和转移有关(P<0.01),而与其组织分化程度、大小无关(P>0.05)。结论:RAGE在宫颈鳞癌组织中尤其是发生转移的宫颈鳞癌组织中呈强阳性表达,可作为宫颈鳞癌浸润、转移的重要判定指标之一,并有望成为基因治疗的靶点。 Objective: To investigate the expression of the receptor of advanced glycosylation end-products ( RAGE ) in humancervical squamous cell carcinoma ( CSCC ) and to explore the relationship of this expression to several factors such as differentiation degree, size and stage of CSCC, and invasion, as well as metastasis of CSCC. Methods: Immunohistochemical staining of tissue microarrays was conducted to detect the expression of RAGE in the following tissue samples: 30 carcinomas in situ, 90 invasive CSCCs without metastasis, 30 invasive CSCCs with metastasis, and 30 cases with normal cervical squamous epithelia. Western blot analysis was used to detect the expression of RAGE in CSCC. Results: The positive expression rates of RAGE were 48.0% in CSCC ( 72/150 ) and 13.3% in normal squamous epithelial tissues of the cervix ( 20/150 ), indicating significant differences between the two conditions. The overexpression of RAGE was correlated with tumor progression, stage, invasion, and metastasis of CSCC ( P 〈 0.01 ), but it had no relation with the degree of differentiation and tumor size ( P 〉 0.05 ). Conclusion: Overexpression of RAGE in CSCC, especially in cervical squamous epithelial tissues with tumor metastasis, can be used as one of the parameters for determining tumor invasion, metastasis, and prognosis.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2011年第19期1201-1204,共4页 Chinese Journal of Clinical Oncology
关键词 宫颈鳞癌 晚期糖基化终产物受体 肿瘤浸润 Cervical squamous cell carcinoma Advanced glycosylation end-product (RAGE) Tumor invasion
  • 相关文献

参考文献4

二级参考文献42

  • 1上官翰京,李志春,张晖萍,周爱东.喉鳞状细胞癌中RAGE与amphoterin的表达[J].山东大学耳鼻喉眼学报,2006,20(3):204-205. 被引量:3
  • 2郭社珂,乔玉环,赵先兰.宫颈癌广泛子宫全切及盆腔淋巴结清除术后血清蛋白质变化[J].中华肿瘤防治杂志,2006,13(22):1730-1733. 被引量:3
  • 3SCHMIDT A M, VIANNA M, GERLACH M , et al. Isolation and characterization of binding proteins for advanced glycation end products from bovine lung which are present on the endothelial cell surface[J]. Biol Chem, 1992,267 : 14987- 14997.
  • 4SCHMIDT A M, YAN S D, YAN S F, The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses[J]. J Clin Invest,2001,108:949-955.
  • 5TAGUCHI A,BLOOD D C,TORO G D,et al. Blockade of RAGE-amphoterin signaling suppresses tumor growth and metastasis[J]. Nature, 2000,405 : 354 - 360.
  • 6KUNIYASU H, OUE N, WAKIKAWA A, et al. Expression of receptors for advanced glycation endproducts (RAGE) is closely associated with the invasire and metastatic activity of gastric cancer [J]. Pathol, 2002,196 : 163-170.
  • 7KUNIYASU H, CHIHARA Y, TAKAHASHI. Coexpression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer[J]. Oncol Rep, 2003,10:445-448.
  • 8HIRATA K, TAKADA M, SUZUKI Y, et al. Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells[J]. Hepatogastroenterology, 2003,50 : 1205 - 1207.
  • 9HIWATASHI K, UENO S, ABEYAMA K, et al. A novel function of the receptor for advanced glycation end-products (RAGE) in association with tumorigenesis and tumor differentiation of HCC[J]. Ann Surg Oncol, 2008,15 : 923 - 933.
  • 10BABETT B, HOFMANN H S, WEIGLE B, et al. Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma[J]. Carcinogenesis, 2005,26: 293 - 301.

共引文献30

同被引文献48

  • 1吕讷男,孔为民.宫颈癌耐药基因的表达及其与同步放化疗疗效的关系[J].肿瘤学杂志,2006,12(5):385-388. 被引量:8
  • 2Cho H, Chung JY, Song KH, et al. Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer [ J ]. BMC cancer, 2014,14 : 545.
  • 3Sapkota D, Bruland O, Costea DE, et al. S100A14 regu- lates the invasive potential of oral squamous cell carcino- ma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9 [ J 1- Eur J Cancer,2011,47 (4) :600-610.
  • 4Jin Q,Chen H,Luo A,et al. S100A14 stimulates cell pro- liferation and induces cell apoptosis at different concentra- tions via receptor for advanced glycation end products (RAGE) [J]. PloS one,2011,6(4) :e19375.
  • 5McKiernan E, McDermott EW, Evoy D, et al. The role of S100 genes in breast cancer progression[ J ]. Turnout Biol, 2011,32 ( 3 ) :441-450.
  • 6Winter JM,Ting AH, Vilardell F,et al. Absence of E-cad- herin expression distinguishes noncohesive from cohesive pancreatic cancer [ J ]. Clin Cancer Rcs, 2008, 14 ( 2 ) : 412-418.
  • 7Chen H,Xu C,Jin Q, et al. S100 protein family in human cancer[J]. Am J Cancer Res,2014,4(2) :89-115.
  • 8Zimmer DB, Chaplin J, Baldwin A, et al. S100-mediated signal transduction in the nervous system and neurological diseases[ J ]. Cell Mol Biol (Noisy-le-grand) , 2005,51 (2) :201-214.
  • 9Zhao FT, Jia ZS, Yang Q, et al. $100A14 promotes thegrowth and metastasis of hepatocellular carcinoma [ J ]. Asian Pac J Cancer Prev,2013,14(6) :3831-3836.
  • 10Zhang X, Li W, Hou Y, et al. Comparative membrane proteomic analysis between lung adenocarcinoma and normal tissue by iTRAQ labeling mass spectrometry [ J 1. Am J Transl Res,2014,6(3) :267-280.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部